rs2278478

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000751.3(CHRND):​c.198+79A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 1,510,956 control chromosomes in the GnomAD database, including 60,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4979 hom., cov: 32)
Exomes 𝑓: 0.28 ( 55905 hom. )

Consequence

CHRND
NM_000751.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.89

Publications

7 publications found
Variant links:
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 3A
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 3B
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • congenital myasthenic syndrome 3C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-232526753-A-G is Benign according to our data. Variant chr2-232526753-A-G is described in ClinVar as Benign. ClinVar VariationId is 680135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.345 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNDNM_000751.3 linkc.198+79A>G intron_variant Intron 2 of 11 ENST00000258385.8 NP_000742.1 Q07001-1
CHRNDNM_001256657.2 linkc.198+79A>G intron_variant Intron 2 of 10 NP_001243586.1 Q07001-2
CHRNDNM_001311196.2 linkc.-74+79A>G intron_variant Intron 2 of 11 NP_001298125.1 Q07001
CHRNDNM_001311195.2 linkc.-74+79A>G intron_variant Intron 2 of 9 NP_001298124.1 Q07001B4E3W4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNDENST00000258385.8 linkc.198+79A>G intron_variant Intron 2 of 11 1 NM_000751.3 ENSP00000258385.3 Q07001-1

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
36013
AN:
152000
Hom.:
4956
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.277
Gnomad AMR
AF:
0.337
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.359
Gnomad SAS
AF:
0.358
Gnomad FIN
AF:
0.238
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.251
GnomAD4 exome
AF:
0.282
AC:
383116
AN:
1358838
Hom.:
55905
AF XY:
0.284
AC XY:
192967
AN XY:
678310
show subpopulations
African (AFR)
AF:
0.0934
AC:
2910
AN:
31172
American (AMR)
AF:
0.443
AC:
19073
AN:
43010
Ashkenazi Jewish (ASJ)
AF:
0.312
AC:
7855
AN:
25142
East Asian (EAS)
AF:
0.364
AC:
14076
AN:
38710
South Asian (SAS)
AF:
0.354
AC:
29381
AN:
83044
European-Finnish (FIN)
AF:
0.241
AC:
12346
AN:
51262
Middle Eastern (MID)
AF:
0.257
AC:
1378
AN:
5354
European-Non Finnish (NFE)
AF:
0.274
AC:
280338
AN:
1024330
Other (OTH)
AF:
0.277
AC:
15759
AN:
56814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
14027
28053
42080
56106
70133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9324
18648
27972
37296
46620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.237
AC:
36057
AN:
152118
Hom.:
4979
Cov.:
32
AF XY:
0.240
AC XY:
17851
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.103
AC:
4284
AN:
41514
American (AMR)
AF:
0.338
AC:
5169
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
1052
AN:
3470
East Asian (EAS)
AF:
0.359
AC:
1849
AN:
5152
South Asian (SAS)
AF:
0.359
AC:
1732
AN:
4828
European-Finnish (FIN)
AF:
0.238
AC:
2517
AN:
10586
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.273
AC:
18572
AN:
67954
Other (OTH)
AF:
0.259
AC:
547
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1356
2711
4067
5422
6778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.247
Hom.:
632
Bravo
AF:
0.242
Asia WGS
AF:
0.395
AC:
1370
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.3
DANN
Benign
0.46
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278478; hg19: chr2-233391463; COSMIC: COSV51317711; COSMIC: COSV51317711; API